Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Other Non-Current Assets: 2023-2024

Historic Other Non-Current Assets for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to $94,000.

  • CG Oncology's Other Non-Current Assets rose 115.09% to $114,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $114,000, marking a year-over-year increase of 115.09%. This contributed to the annual value of $94,000 for FY2024, which is 97.99% down from last year.
  • CG Oncology's Other Non-Current Assets amounted to $94,000 in FY2024, which was down 97.99% from $4.7 million recorded in FY2023.
  • CG Oncology's 5-year Other Non-Current Assets high stood at $4.7 million for FY2023, and its period low was $94,000 during FY2024.
  • In the last 2 years, CG Oncology's Other Non-Current Assets had a median value of $2.4 million in 2023 and averaged $2.4 million.
  • Data for CG Oncology's Other Non-Current Assets shows a maximum YoY slumped of 97.99% (in 2024) over the last 5 years.
  • Over the past 2 years, CG Oncology's Other Non-Current Assets (Yearly) stood at $4.7 million in 2023, then tumbled by 97.99% to $94,000 in 2024.